Cargando…
Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysis
Cardiovascular disease is the leading cause of morbidity and mortality in maintenance hemodialysis (MHD) patients. We evaluated the role of serum catalytic iron (SCI) as a biomarker for coronary artery disease (CAD) in patients on MHD. SCI was measured in 59 stable MHD patients. All patients underwe...
Autores principales: | Rajapurkar, M. M., Lele, S. S., Malavade, T. S., Kansara, M. R., Hegde, U. N., Gohel, K. D., Gang, S. D., Shah, S. V., Mukhopadhyay, B. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764705/ https://www.ncbi.nlm.nih.gov/pubmed/24049267 http://dx.doi.org/10.4103/0971-4065.116293 |
Ejemplares similares
-
Increased serum catalytic iron may mediate tissue injury and death in patients with COVID-19
por: Chakurkar, Vipul, et al.
Publicado: (2021) -
Percutaneous endovascular management of recurrent aneurysm of transplant renal artery anastomosed to internal iliac artery
por: Hegde, Umapati N., et al.
Publicado: (2008) -
Is carbon dioxide a safe and good alternative for diatrizoate meglumine as a contrast in digital subtraction angiography?
por: Hegde, U. N., et al.
Publicado: (2009) -
Evaluation of iron stores in hemodialysis patients on maintenance ferric Carboxymaltose dosing
por: Diebold, Matthias, et al.
Publicado: (2019) -
Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis
por: ZHENG, Shubei, et al.
Publicado: (2018)